A series of betamethasone tests from 2016 raise questions about drug rules enforcement in Pennsylvania — that’s one of the takeaways from the latest commentary by former Indiana Horse Racing Commission executive director Joe Gorajec.
Gorajec outlined three positives for the corticosteroid which resulted from races in 2016; the first two were between 10 and 100 picograms. A third test in the same range, from the top Standardbred trainer in the country, resulted in no violations or suspensions and soon after, the positives from the first two tests were rescinded.
As outlined in a blog post for the website Horse Racing Reform, Gorajec described difficulty using Pennsylvania’s Right-to-Know laws, as he requested information on state drug testing thresholds and results from 2016 and 2017 and was sometimes told his requests could not be fulfilled because records did not exist. In one case, Gorajec eventually got the documentation he had been told didn’t exist — after he filed an appeal to the Pennsylvania Department of Agriculture’s denial of his records request.
Gorajec also encountered a lack of clarity about what thresholds were being used in the state’s drug testing program at the time — and whether the laboratory and the commission may have been working off two different threshold lists.
Read more at Horse Racing Reform
New to the Paulick Report? Click here to sign up for our daily email newsletter to keep up on this and other stories happening in the Thoroughbred industry.
Copyright © 2018 Paulick Report.